NCT05016206View on ClinicalTrials.gov

A Study of the Cardiac Effects of Danicopan in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 26, 2018

Primary Completion Date

October 12, 2018

Study Completion Date

October 12, 2018

Conditions
Healthy
Interventions
DRUG

Danicopan

Danicopan tablets administered as a single oral dose.

DRUG

Moxifloxacin-matching Placebo

Moxifloxacin-matching placebo was administered as a single oral dose.

DRUG

Danicopan-matching placebo

Danicopan-matching placebo was administered as a single oral dose.

DRUG

Moxifloxacin

Moxifloxacin 400 mg was administered as a single tablet oral dose.

Trial Locations (1)

85283

Clinical Trial Site, Tempe

Sponsors
All Listed Sponsors
collaborator

Achillion, a wholly owned subsidiary of Alexion

INDUSTRY

lead

Alexion Pharmaceuticals, Inc.

INDUSTRY